Prio Wealth Limited Partnership Abb Vie Inc. Transaction History

Prio Wealth Limited Partnership

$3.43 Billion
Q1 2024

A detailed history of Prio Wealth Limited Partnership transactions in Abb Vie Inc. stock. As of the latest transaction made, Prio Wealth Limited Partnership holds 59,386 shares of ABBV stock, worth $11.5 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

59,386

Previous 44,118 34.61%

Holding current value

$11.5 Million

Previous $6.84 Million 58.19%

% of portfolio

0.32%

Previous 0.24%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $2.44 Million - $2.78 Million	15,268 Added 34.61%	59,386 $10.8 Million
Q4 2023 Jan 22, 2024	BUY	$137.6 - $154.97 $25,180 - $28,359	183 Added 0.42%	44,118 $6.84 Million
Q3 2023 Oct 31, 2023	SELL	$133.59 - $154.65 $188,629 - $218,365	-1,412 Reduced 3.11%	43,935 $6.55 Million
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $395,807 - $492,556	-2,987 Reduced 6.18%	45,347 $6.11 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $5.61 Million - $6.46 Million	-38,815 Reduced 44.54%	48,334 $7.7 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $1.88 Million - $2.26 Million	-13,611 Reduced 13.51%	87,149 $0
Q3 2022 Feb 27, 2023	SELL	$134.21 - $153.93 $1.04 Million - $1.19 Million	-7,714 Reduced 8.1%	87,493 $11.7 Million
Q2 2022 Feb 27, 2023	BUY	$137.62 - $174.96 $1.11 Million - $1.41 Million	8,058 Added 9.25%	95,207 $14.6 Million
Q1 2022 Feb 21, 2023	BUY	$131.98 - $163.75 $1.59 Million - $1.97 Million	12,046 Added 13.82%	99,195 $16.1 Million
Q4 2021 Feb 17, 2022	SELL	$107.43 - $135.93 $34,377 - $43,497	-320 Reduced 0.32%	100,760 $13.6 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $6,277 - $7,126	-59 Reduced 0.06%	101,080 $10.9 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $510,058 - $568,234	-4,848 Reduced 4.57%	101,139 $11.4 Million
Q1 2021 May 06, 2021	SELL	$102.3 - $112.62 $309,252 - $340,450	-3,023 Reduced 2.77%	105,987 $11.5 Million
Q4 2020 Feb 04, 2021	SELL	$80.49 - $108.67 $100,532 - $135,728	-1,249 Reduced 1.13%	109,010 $11.7 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $118,727 - $139,347	-1,382 Reduced 1.24%	110,259 $9.66 Million
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $558,272 - $747,051	-7,609 Reduced 6.38%	111,641 $11 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $690,666 - $1.05 Million	-10,708 Reduced 8.24%	119,250 $9.09 Million
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $959,328 - $1.2 Million	-13,300 Reduced 9.28%	129,958 $11.5 Million
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $262,122 - $315,146	-4,162 Reduced 2.82%	143,258 $10.8 Million
Q2 2019 Jul 18, 2019	SELL	$65.7 - $83.98 $581,445 - $743,223	-8,850 Reduced 5.66%	147,420 $10.7 Million
Q1 2019 May 03, 2019	SELL	$77.14 - $90.79 $294,829 - $346,999	-3,822 Reduced 2.39%	156,270 $12.6 Million
Q4 2018 Feb 06, 2019	SELL	$77.85 - $96.01 $44,763 - $55,205	-575 Reduced 0.36%	160,092 $14.8 Million
Q3 2018 Nov 07, 2018	BUY	$88.91 - $98.84 $372,355 - $413,941	4,188 Added 2.68%	160,667 $15.2 Million
Q2 2018 Aug 06, 2018	SELL	$89.78 - $106.23 $86,099 - $101,874	-959 Reduced 0.61%	156,479 $14.5 Million
Q1 2018 Apr 17, 2018	BUY	$92.01 - $123.21 $14.5 Million - $19.4 Million	157,438 New	157,438 $14.9 Million

Others Institutions Holding ABBV

# of Institutions

3,689

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prio Wealth Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Prio Wealth Limited Partnership with notifications on news.

Account

Prio Wealth Limited Partnership Abb Vie Inc. Transaction History